Literature DB >> 16634244

Dysnatremias: why are patients still dying?

Steven G Achinger1, Michael L Moritz, Juan Carlos Ayus.   

Abstract

Dysnatremias are a common clinical entity that are often associated with poor outcomes. This review takes a case study approach to understand how dysnatremias can result in devastating neurologic consequences. Concrete guidelines are provided for prevention, early recognition and treatment along with a discussion of how urinary electrolytes and osmolality can be used to guide therapy. Case studies in hyponatremic encephalopathy include the post-operative state, thiazide diuretics, extreme exercise and DDAVP use. Reasons to avoid using hypotonic parenteral fluids, risk factors for hyponatremic encephalopathy such as age, gender, and hypoxia, and the appropriate use of 3% sodium chloride are discussed. Case studies in hypernatremia include hypernatremia in the ICU setting and the emerging condition of breastfeeding-associated hypernatremia in infants.

Entities:  

Mesh:

Year:  2006        PMID: 16634244     DOI: 10.1097/01.smj.0000209351.55330.76

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  3 in total

Review 1.  Impact of perioperative hyponatremia in children: A narrative review.

Authors:  Cheme Andersen; Arash Afshari
Journal:  World J Crit Care Med       Date:  2014-11-04

2.  A systematic review and meta-analysis of thiazide-induced hyponatraemia: time to reconsider electrolyte monitoring regimens after thiazide initiation?

Authors:  Jennifer Barber; Tricia M McKeever; Sarah E McDowell; Jennifer A Clayton; Robin E Ferner; Richard D Gordon; Michael Stowasser; Kevin M O'Shaughnessy; Ian P Hall; Mark Glover
Journal:  Br J Clin Pharmacol       Date:  2015-04       Impact factor: 4.335

3.  Hourly oral sodium chloride for the rapid and predictable treatment of hyponatremia.

Authors:  Eric Kerns; Shweta Patel; David M Cohen
Journal:  Clin Nephrol       Date:  2014-12       Impact factor: 0.975

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.